Akebia Therapeutics Inc
NASDAQ:AKBA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Akebia Therapeutics Inc
NASDAQ:AKBA
|
US |
|
N
|
Nordstrom Inc
SWB:NRD
|
US |
|
S
|
Silla SG Co Ltd
KOSDAQ:025870
|
KR |
Wall St Price Targets
AKBA Price Targets Summary
Akebia Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for AKBA is 4.28 USD with a low forecast of 3.03 USD and a high forecast of 6.3 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AKBA's stock price target?
Price Target
4.28
USD
According to Wall Street analysts, the average 1-year price target for AKBA is 4.28 USD with a low forecast of 3.03 USD and a high forecast of 6.3 USD.
What is the Revenue forecast for Akebia Therapeutics Inc?
Projected CAGR
12%
The compound annual growth rate for Revenue over the next 8 years is 12%.
What is the Operating Income forecast for Akebia Therapeutics Inc?
Projected CAGR
39%
The compound annual growth rate for Operating Income over the next 8 years is 39%.
